Apr 19, 2023 / 01:00AM GMT
Operator
Thank you for standing by, and welcome to the Arovella Therapeutics AACR poster webinar and Q&A today. (Conference Instructions)
On behalf of Arovella today, on the line we have the CEO and Managing Director, Dr. Michael Baker; and Senior VP of Development and Translational Medicine, Dr. Mini Bharathan. To begin over, I'll hand it over to Michael. Please go ahead.
Michael Baker - Arovella Therapeutics Limited - CEO & Managing Director
Right. Thanks, Matt. We're delighted to be on the webinar today, talking about the data that we just presented at AACR or the American Association for Cancer Research. And for those of you that don't know, it is one of the most significant cancer events on the calendar, certainly based in the US in Orlando this year.
And so we're delighted that our abstract was accepted and delighted to have presented. And we're going to talk through some of that data today and hoping that people can take away a lot from it. But certainly, delighted to have me on the call as well today, talking through some of that data.
Arovella Therapeutics Ltd AACR Conference Transcript
Apr 19, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers